Rockwell Medical (RMTI) Income from Continuing Operations (2010 - 2026)
Rockwell Medical (RMTI) posted Income from Continuing Operations of 7211000.0 for Q1 2026, down 757.43% on a QoQ basis from 841000.0 in Q4 2025, and down 290.63% year-over-year from 3782752.49 in Q1 2025.
Rockwell Medical (RMTI) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Rockwell Medical's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 7211000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 290.63% year-over-year to 7211000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12729000.0 (down 1160.3% YoY) and the FY2025 annual result came in at 11353000.0, up 86.57% from the prior year.
- Income from Continuing Operations was 7211000.0 for Q1 2026 at Rockwell Medical, down from 841000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1517000.0 in Q3 2024 and bottomed at 7211000.0 in Q1 2026.
- A 5-year average of 2550294.12 and a median of 2081000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations jumped 170.82% — and 2025, when it tumbled 2748.98%.
- Rockwell Medical's Income from Continuing Operations stood at 2362000.0 in 2022, then grew by 20.53% to 1877000.0 in 2023, then surged by 58.5% to 779000.0 in 2024, then fell by 7.96% to 841000.0 in 2025, then sank by 757.43% to 7211000.0 in 2026.
- Business Quant data shows RMTI's Income from Continuing Operations at 7211000.0 in Q1 2026, 841000.0 in Q4 2025, and 2081000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -7.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.21 Mn |
| Dec 31, 2025 | -841,000.00 |
| Sep 30, 2025 | -2.08 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | -779,000.00 |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -1.88 Mn |
| Sep 30, 2023 | -2.14 Mn |
| Jun 30, 2023 | -3.39 Mn |
| Mar 31, 2023 | -1.79 Mn |
| Dec 31, 2022 | -2.36 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.97 Mn |
| Mar 31, 2022 | -7.17 Mn |
| Dec 31, 2021 | -9.40 Mn |
| Sep 30, 2021 | -7.58 Mn |
| Jun 30, 2021 | -8.40 Mn |